Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 10/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30115053 | 1.00 | HCAR2 (0.62) | HCAR2TDP1LMNAATMCA12 | |
| SCHEMBL3482913 | 1.00 | HCAR2 (0.62) | HCAR2TDP1LMNAATMCA12 | |
| Propane SCHEMBL7773741 | 0.96 | HCAR2 (0.63) | HCAR2TDP1LMNAATMCA12 | |
| SCHEMBL2475186 | 0.92 | TDP1 (0.56) | HCAR2TDP1LMNAATMCA12 | |
| SCHEMBL2475190 | 0.92 | TDP1 (0.56) | HCAR2TDP1LMNAATMCA12 | |
| SCHEMBL2478667 | 0.92 | TDP1 (0.56) | HCAR2TDP1LMNAATMCA12 | |
| SCHEMBL21767944 | 0.91 | HCAR2 (0.53) | HCAR2TDP1LMNAATMCA12 | |
| SCHEMBL1408806 | 0.89 | HCAR2 (0.65) | HCAR2TDP1LMNAATM | |
| SCHEMBL11685039 | 0.89 | HCAR2 (0.65) | HCAR2TDP1LMNAATM | |
| SCHEMBL1408812 | 0.89 | HCAR2 (0.65) | HCAR2TDP1LMNAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113454090-B | Compounds having a polycyclic aromatic skeleton and endoperoxide compounds thereof | 川崎化成工业株式会社 | 2024-08-23 | — | — | CN | disclosed |
| US-12065521-B2 | Compound having polycyclic aromatic skeleton, and endoperoxide compound of same | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2024-08-20 | — | — | US | disclosed |
| US-20220127385-A1 | COMPOUND HAVING POLYCYCLIC AROMATIC SKELETON, AND ENDOPEROXIDE COMPOUND OF SAME | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2022-04-28 | — | — | US | disclosed |
| US-8420764-B2 | Compound having silsesquioxane skeleton and its polymer | JNC CORPORATION (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20120178894-A1 | COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER | INAGAKI JYUN-ICHI (JP) | 2012-07-12 | — | — | US | disclosed |
| US-7705105-B2 | A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; | CHISSO PETROCHEMICAL CORPORATION (JP) | 2010-04-27 | — | — | US | disclosed |
| US-20070190344-A1 | Verification of translation | JNC CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | CHISSO CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | C1S, H1-4, H1-0 | HCAR2 2928/4885TDP1 4164/4885LMNA 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.